Prescription drug · ANDA
Cefepime NDC 60505-6147
Cefepime hydrochloride 2 g/1 · Injection, Powder, For solution · Intravenous · Apotex Corp.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 60505-6147-0 | 60505614700 | 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6147-0) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSEMarketed from Mar 30, 2017 | |
| 60505-6147-4 | 60505614704 | 10 VIAL, SINGLE-DOSE in 1 CARTON (60505-6147-4) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSEMarketed from Mar 30, 2017 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cefepime
- Generic name (nonproprietary)
- cefepime
- Active ingredients
- Cefepime hydrochloride — 2 g/1
- Dosage form
- Injection, Powder, For solution
- Route
- Intravenous
- Labeler
- Apotex Corp.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203704
- Marketing start
- Listing expires
- Other FDA classes
- Cephalosporins (Chemical structure)
- Identifiers
- Product ID 60505-6147_e1dbb0ac-a9df-41c4-acb2-3e3f5732f7efSPL ID e1dbb0ac-a9df-41c4-acb2-3e3f5732f7efSPL set ID dd641c7f-b857-48ff-bd9d-747e0c3cc89fRxCUI 1665088, 1665093UNII I8X1O0607PUPC 0360505614608, 0360505614707
- Pharmacologic class
- Cephalosporin Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N460505614700followed by a unit qualifier and the quantityPackage 60505-6147-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.
Other NDCs under ANDA 203704
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Cefepimecefepime hydrochloride | Cefepime hydrochloride 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | Qilu Pharmaceutical Co., Ltd. | 67184-1003 |
| Cefepimecefepime hydrochloride | Cefepime hydrochloride 500 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | Qilu Pharmaceutical Co., Ltd. | 67184-1002 |
| Cefepimecefepime hydrochloride | Cefepime hydrochloride 2 g/1 | Injection, Powder, For solutionIntravenous | Qilu Pharmaceutical Co., Ltd. | 67184-1004 |
| Cefepime | Cefepime hydrochloride 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | Apotex Corp. | 60505-6144 |
| Cefepime | Cefepime hydrochloride 2 g/1 | Injection, Powder, For solutionIntravenous | Apotex Corp. | 60505-6145 |
| Cefepime | Cefepime hydrochloride 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | Apotex Corp. | 60505-6146 |
| Cefepime | Cefepime hydrochloride 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | Apotex Corp. | 60505-6245 |
| Cefepime | Cefepime hydrochloride 2 g/1 | Injection, Powder, For solutionIntravenous | Apotex Corp. | 60505-6246 |